Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1589 of 6351
-
Could a simpler dental procedure spare kids from a painful root canal?
Disease control Recruiting nowThis randomised controlled trial aims to compare treatment outcomes between pulpotomy and pulpectomy when used to treat vital primary molars diagnosed with symptomatic irreversible pulpitis. Compared to the standard pulpectomy treatment, pulpotomy is a technically simpler procedu…
Sponsor: Qatar University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug trial aims to ease daily life for myasthenia gravis patients
Disease control Recruiting nowThe primary objective of the study is to evaluate the effectiveness of Ravulizumab in improving MG-ADL in an early-stage AChR+ gMG population.
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo inhaler aims to improve breathing in COPD patients
Disease control CompletedThis study will assess the safety and efficacy of fixed dose combinations of ensifentrine with two different glycopyrrolate dose levels compared to placebo and to the individual components of the fixed dose combinations, each administered twice a day via standard jet nebulizer, i…
Phase 2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Cancer-Killing virus trial launches for patients out of options
Disease control Recruiting nowThis study employs a single-arm, open-label, non-randomized, dose-escalation design to investigate the safety, tolerability, and efficacy of GO306 Recombinant Oncolytic Vaccinia Virus Injection. * Part 1: Utilizes the 3+3 design principle to evaluate the safety and tolerability …
Phase 1 • Sponsor: GeneSail Biotech (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New tetanus shot under study in 10,000 people
Prevention Recruiting nowThe injury and wound conditions of the enrolled patients will be documented. A follow-up at 90 days post-administration will determine the clinical outcome of tetanus prophylaxis, specifically whether tetanus occurred. The registry will also employ selective safety data collectio…
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 08:09 UTC
-
Hypnosis tapes for kids: a new way to ward off teen depression?
Prevention Recruiting nowThe goal of this trial is to learn if listening daily to online hypnosis exercises helps to improve mental health and self-esteem in primary school children. In the future we also hope to see if it can prevent feelings of depession or anxiety when these children have become teena…
Sponsor: St. Antonius Hospital • Aim: Prevention
Last updated Jun 26, 2026 13:58 UTC
-
Could a simple inhaler cut lung complications after cancer surgery?
Disease control Recruiting nowThe objective of the study is to evaluate, in a clinical trial, the efficacy of peri operative administration of long-acting inhaled ß-2 mimetics on the occurrence of postoperative pulmonary complications
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New sedative ciprofol aims to cut heart injury after lung surgery
Disease control Recruiting nowMyocardial injury after noncardiac surgery (MINS) refers to postoperative elevation of cardiac troponin (cTn) levels caused by underlying ischemic mechanisms (i.e., coronary artery supply-demand imbalance or atherosclerotic thrombosis) without obvious non-ischemic causes (such as…
Phase 4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Radioactive therapy takes aim at Hard-to-Treat kidney cancer
Disease control OngoingThis study aims to evaluate the efficacy and safety of 177Lu-PSMA-617 as a systemic therapy in patients with PSMA-positive advanced clear cell renal cell carcinoma (ccRCC). The name of the study drug involved in this research study is: -177Lu-PSMA-617 (a type of radioligand the…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Heart valve repair patients: which blood thinner is safest?
Disease control Recruiting nowMitral regurgitation (MR) is the most common valvular heart disease, affecting approximately 24.2 million people worldwide (with a higher prevalence in older age groups). Transcatheter edge-to-edge repair (TEER) is now a well-established strategy in high-risk patients with MR. Gl…
Phase 4 • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Donor t cells aim to fight severe COVID-19
Disease control OngoingThe goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of allogeneic SARS-CoV-2-Specific T cells (LB-DTK-COV19) in patients with persistent clinical symptoms following a positive SARS-CoV-2 PCR test for 14 days or longer. The main questions it aims …
Phase 1 • Sponsor: LucasBio • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New surgery may offer better reflux control for obese patients
Disease control Recruiting nowThis randomized clinical trial aims to compare two surgical techniques for the treatment of obesity in patients who also have symptoms of gastroesophageal reflux disease (GERD). The study will compare Nissen-Sleeve Gastrectomy (N-SG)-a sleeve gastrectomy combined with a reflux-pr…
Sponsor: Jagiellonian University • Aim: Disease control
Last updated Jun 26, 2026 13:41 UTC
-
New pill targets Hard-to-Treat KRAS cancers in first human trial
Disease control Recruiting nowThe purpose of this first-in-human study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AMG 410 when administered alone or in combination with other agents in participants with advanced or metastatic solid tumors…
Phase 1 • Sponsor: Amgen • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New pill could help ITP patients who failed other treatments
Disease control Recruiting nowThe purpose of the phase 1 part of this study was to evaluate how well pirtobrutinib is tolerated and what side effects may occur. The phase 2 part of the study will further investigate efficacy and safety of multiple pirtobrutinib dosages versus placebo. The study drug will be …
Phase 1/2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New epilepsy drug SPN-817 put to the test in Year-Long safety study
Disease control Recruiting nowThis is a Phase 2b open-label extension study to evaluate the long-term safety and efficacy of SPN-817.
Phase 2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Special baby formula may boost growth in heart defect infants
Disease control Recruiting nowThis study is testing whether a special formula called Fortini, which is a high-calorie, low osmolality formula can help high-risk babies with single ventricle physiology grow better after their initial Stage 1 surgical palliation. These babies often struggle to gain weight, whic…
Sponsor: Driscoll Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for tough leukemia? early trial of AOH1996 begins
Disease control Recruiting nowThis phase 1 trial tests safety, side effects, and best dose of AOH1996 for the treatment of patients with acute myeloid leukemia (AML) that has come back after a period of improvement (relapsed) or AML that has not responded to previous treatment (refractory). AOH1996 is in a cl…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug candidate BL-M05D1 enters early human trials for tough cancers
Disease control OngoingThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects with Advanced or Metastatic Solid Tumors.
Phase 1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
3D tech may sharpen heart valve placement in leaky aortic disease
Disease control By invitation onlyThis study will evaluate the safety and efficacy of postmarket bioprosthetic aortic valve in patients with severe aortic regurgitation undergoing transapical transcatheter aortic valve replacement based on 3D simulation technology using a prospective, randomized controlled study.
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a mindfulness program curb youth suicide? new study aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to develop and evaluate youth-focused intervention programs for suicide and self-harm that are tailored to the psychological, developmental, and cultural characteristics of Korean adolescents and young adults. The study examines whether two stru…
Sponsor: Ajou University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC